SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : CEPH
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Techperson who wrote (232)5/9/1997 3:59:00 PM
From: Mel Kaplan   of 998
 
T. Who is Dr. Tracy and whom does he represent? The statement
is obviously a public relations attempt to interfere with a sound
decision on medical grounds, the emotional appeal notwithstanding.
CEPH's CEO Baldini has tried every trick in the book to politically
influence the FDA, including his blatant 1995 complaints, also on
an emotional level. Patients' cries are surely heart-breaking, but
should they be treated with a useless drug, which even may represent
a risk based on the excessive mortality of the treated patients in the
European study? At some point, the investment community has to
face reality, and allow the FDA to keep up standards of drug treatment. The Advisory Panel included eminent and wise neurologists, who certainly felt for the ALS patients. Mel
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News